PRESS RELEASE published on 01/24/2024 at 17:29, 9 months 29 days ago Dividend Declaration M&G Credit Income Investment Trust plc has declared an interim dividend payment of 2.14 pence per Ordinary Share, representing an annualised rate of SONIA plus 4% for the financial year ended 31 December 2023. The dividend will be paid on 23 February 2024 to ordinary shareholders on the register on 2 February 2024. For further details about the dividend declaration and payment, please refer to the official press release. Dividend Declaration Financial Year M&G Credit Income Investment Trust Plc Interim Dividend Payment Ordinary Shareholders
PRESS RELEASE published on 10/17/2023 at 18:58, 1 year 1 month ago M&G Credit Income Investment Trust plc: Net Asset Value(s)
Published on 11/22/2024 at 23:55, 3 hours 27 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 3 hours 52 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 4 hours 17 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 4 hours 52 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 9 hours 7 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 9 hours 28 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 10 hours 26 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 11 hours 22 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 1 day 20 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 8 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 9 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 9 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024